What Can We Learn From Geron Corporation (GERN)’s Valuation Ratios?

0
15
KOSK
KOSK

Geron Corporation (NASDAQ:GERN) finished Thursday with a subtraction of -$0.08 to close at $2.46, a downside of -3.15 percent. An average of 4,249,920 shares of common stock have been traded in the last five days. There was a fall of -$0.44 in the past week, and it reached a new high 23 times over the past 12 months. The last 20 days have seen an average of 4,211,295 shares traded, while the 50-day average volume stands at 3,883,756.

GERN stock has increased by 2.50% in the last month. The company shares reached their 1-month lowest point of $2.20 on 08/23/22. With the stock rallying to its 52-week high on 09/14/22, shares of the company touched a low of $0.99 and a high of $3.06 in 52 weeks. It has reached a new high 18 times so far this year and achieved 101.64% or $1.24 in price. In spite of this, the price is down -19.61% from the 52-week high.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


Valuation Metrics

Geron Corporation (GERN) stock’s beta is 0.77. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 767.92, the price-to-book (PB) ratio at 7.03.

Financial Health

The quick ratio of Geron Corporation for the three months ended March 30 was 4.90, and the current ratio was 4.90, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.32 and a total debt to equity ratio of 0.36 for the quarter ending March 30. Its gross profit as reported stood at $115.39 million compared to revenue of $1.39 million.

Earnings Surprise

For the three-month period that ended March 30, Geron Corporation had $143.23 million in cash and short-term investments compared to $45.26 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$28.12 million in the quarter, while revenues were shrunk -5.16%. The analyst consensus anticipated Geron Corporation’s latest quarter earnings to come in at -$0.1 per share, but it turned out to be -$0.09, a 10.00% surprise. For the quarter, EBITDA amounted to -$27.3 million. Shareholders own equity worth $377.82 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Geron Corporation (GERN) price momentum. RSI 9-day as of the close on 22 September was 40.05%, suggesting the stock is Neutral, with historical volatility in this time frame at 64.49%.

As of today, GERN’s price is $2.60 -15.17% or -$0.44 from its 5-day moving average. GERN is currently trading +4.68% higher than its 20-day SMA and +74.47% higher than its 100-day SMA. However, the stock’s current price level is +32.97% above the SMA50 and +86.36% above the SMA200.

The stochastic %K and %D were 21.40% and 35.45%, respectively, and the average true range (ATR) was 0.18. With the 14-day stochastic at 7.69% and the average true range at 0.18, the RSI (14) stands at 47.29%. The stock has reached -0.16 on the 9-day MACD Oscillator while the 14-day reading was at -0.14.

Analyst Ratings

The consensus rating for Geron Corporation (GERN) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell GERN, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 4 others rate it as a “buy”.

What is GERN’s price target for the next 12 months?

Analysts predict a range of price targets between $3.00 and $7.00, with a median target of $4.00. Taking a look at these predictions, the average price target given by analysts for Geron Corporation (GERN) stock is $4.20.

LEAVE A REPLY

Please enter your comment!
Please enter your name here